NRF2 Activation Inhibits Both TGF-β1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment

المؤلفون المشاركون

Furue, Masutaka
Mitamura, Yasutaka
Murai, Mika
Mitoma, Chikage

المصدر

Oxidative Medicine and Cellular Longevity

العدد

المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-10، 10ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2018-08-07

دولة النشر

مصر

عدد الصفحات

10

التخصصات الرئيسية

الأحياء

الملخص EN

Systemic fibrosing or sclerotic disorders are life-threatening, but only very limited treatment modalities are available for them.

In recent years, periostin (POSTN), a major extracellular matrix component, was established by several studies as a novel key player in the progression of systemic fibrotic disease.

In this research, we revealed the involvement of oxidative stress in the expression of POSTN induced by TGF-β1 and IL-13 in dermal fibroblasts.

We found that the antioxidant cinnamaldehyde activated the NRF2/HMOX1 pathway.

Cinnamaldehyde also alleviated TGF-β1- and IL-13-mediated production of reactive oxygen species and subsequent POSTN upregulation in dermal fibroblasts.

In contrast, NRF2 silencing abolished the cinnamaldehyde-mediated downregulation of POSTN.

These results suggest that cinnamaldehyde is a broad inhibitor of POSTN expression covering both TGF-β1 and IL-13 signaling.

Cinnamaldehyde may thus be beneficial for the treatment of systemic fibrotic diseases.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Mitamura, Yasutaka& Murai, Mika& Mitoma, Chikage& Furue, Masutaka. 2018. NRF2 Activation Inhibits Both TGF-β1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment. Oxidative Medicine and Cellular Longevity،Vol. 2018, no. 2018, pp.1-10.
https://search.emarefa.net/detail/BIM-1211046

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Mitamura, Yasutaka…[et al.]. NRF2 Activation Inhibits Both TGF-β1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment. Oxidative Medicine and Cellular Longevity No. 2018 (2018), pp.1-10.
https://search.emarefa.net/detail/BIM-1211046

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Mitamura, Yasutaka& Murai, Mika& Mitoma, Chikage& Furue, Masutaka. NRF2 Activation Inhibits Both TGF-β1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment. Oxidative Medicine and Cellular Longevity. 2018. Vol. 2018, no. 2018, pp.1-10.
https://search.emarefa.net/detail/BIM-1211046

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1211046